Philipp Lachenmann: DELPHI Rationale


Scientific Symposia 2007

Oncogenes meet metabolism - from deregulated genes to a broader understanding of tumour physiology

Dr. Dominik Mumberg, Apoptosis & Signal Transduction Research, Bayer Schering Pharma AG, Berlin, Germany
Dr. T. Steger-Hartmann, Laboratory Diagnostics, Genetics & Ecotoxicology, Bayer Schering Pharma AG, Berlin, Germany
Guido Kroemer, Institut Gustave Roussy, France, Research Director INSERM
Hector Keun, Imperial College, London

Berlin, November 14-16, 2007



Sparking signals: kinases as molecular signal transducers and pharmacological drug targets in inflammation

Dr. Arne von Bonin, Dr. Ulrich Zügel, CRBA Inflammation, Bayer Schering Pharma AG, Berlin, Germany
Prof. Dr. Gottfried Baier, Human Genetics Department, Medical University of Innsbruck
Prof. Dr. Burkhart Schraven, Institute for Immunology, University of Magdeburg

Potsdam-Hermannswerder, June 20-22, 2007




Dr. Hilmar Weinmann, Dr. Stefan Jaroch, Med. Chemistry 1, Bayer Schering Pharma AG, Berlin, Germany
Prof. Manfred T. Reetz, Dr. Benjamin List, Max Planck Institute for Coal Research, Mühlheim/Ruhr

Berlin, April 18 - 20, 2007



Progestins and the mammary gland – from basic science to clinical applications

Dr. Dr. Christiane Otto, CRBA Gynecology & Andrology - Female Healthcare, Bayer Schering Pharma AG, Berlin, Germany
Prof. Dr. Orla Conneely, Baylor College, Houston, TX, USA

Berlin, March 21 - 23, 2007




Live Debate: What to Do When Kidneys, Livers and Hearts Are Getting Scarce?

09.03.2018, Berlin | While more than 10,000 people in Germany are desperately waiting for a donor...

Big Data Means Big Responsibility. The Use of Data in the Healthcare Sector

24.02.2018, Erlangen | The digitalization of medicine is making big strides. The integration of previously distinct...

Visions of Synthetic Biology

16.02.2018, Berlin | Life is what you make it – this is the motto of synthetic...